Form 8-K - Current report:
SEC Accession No. 0000950170-25-093456
Filing Date
2025-07-03
Accepted
2025-07-02 20:30:37
Documents
10
Period of Report
2025-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pyxs-20250701.htm   iXBRL 8-K 48911
  Complete submission text file 0000950170-25-093456.txt   158500

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pyxs-20250701.xsd EX-101.SCH 25999
12 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20250701_htm.xml XML 4914
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40881 | Film No.: 251103476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)